Amicus Curiae Brief — Anthony Marciano, Applicant v. Eric Adams, Mayor of the City of New York, et al.
Supreme Court briefSep 26, 2022
Ask Donna
What actually matters in this document.
Text
NO. 22A178
In the
Supreme Court of the United States
ANTHONY MARCIANO, individually and on behalf
of all other individuals similarly situated,
Applicant/Petitioner,
v.
ERIC ADAMS, Mayor of the City of New York, in his official capacity;
ASHWIN VASAN, Commissioner of Health and Mental Hygiene, in
his official capacity; KEECHANT SEWELL, Police Commissioner, in
her official capacity; THE NEW YORK CITY BOARD OF HEALTH;
and THE CITY OF NEW YORK,
Respondents.
On Emergency Application for Writ of Injunction
to the Honorable Clarence Thomas
BRIEF OF AMICUS CURIAE
PHYSICIANS FOR INFORMED CONSENT
IN SUPPORT OF APPLICANT/PETITIONER
GREGORY J. GLASER
COUNSEL OF RECORD
4399 BUCKBOARD DRIVE #423
COPPEROPOLIS, CA 95228
(925) 642-6651
GREG@PICPHYSICIANS.ORG
COUNSEL FOR AMICUS CURIAE
SEPTEMBER 24, 2022
SUPREME COURT PRESS
♦
(888) 958-5705
♦
BOSTON, MASSACHUSETTS
i
TABLE OF CONTENTS
Page
TABLE OF AUTHORITIES .......................................................................................... ii
IDENTITY AND INTEREST OF AMICUS CURIAE .................................................. 1
SUMMARY OF ARGUMENT ....................................................................................... 1
ARGUMENT .................................................................................................................. 2
A. INFORMED CONSENT/REFUSAL IN VACCINATION IS A FUNDAMENTAL RIGHT
TRIGGERING STRICT SCRUTINY. ........................................................................... 2
B. THERE IS NO EVIDENCE THAT COVID-19 VACCINES PREVENT THE INFECTION
OR TRANSMISSION OF SARS-COV-2 OR COVID-19, AND IN FACT THERE IS
EVIDENCE TO THE CONTRARY (THAT IT HAS A NEGATIVE EFFECT ON
IMMUNITY) .......................................................................................................... 9
C. THOSE PREVIOUSLY INFECTED WITH COVID-19 SHOULD NOT HAVE LESS
RIGHTS THAN THOSE VACCINATED FOR COVID-19 ............................................ 12
D. COVID-19 VACCINES HAVE HAD NO MEASURABLE IMPACT ON THE COVID19 MORTALITY RATE .......................................................................................... 13
CONCLUSION............................................................................................................. 15
ii
TABLE OF AUTHORITIES
Page
TABLE OF AUTHORITIES
CASES
Addington v. Texas,
441 U.S. 418 (1979) ................................................................................................ 4
Carey v. Population Services Intl,
431 U.S. 678 (1977) ................................................................................................ 4
City of Newark v. JS,
279 N.J. Super. 178 (1993) ..................................................................................... 4
Foucha v. Louisiana,
504 U.S. 71 (1992) .................................................................................................. 4
Green v. Edwards,
164 W.Va. 326 (1980) ............................................................................................. 4
Jacobson v. Massachusetts,
197 U.S. 11 (1905) .................................................................................................. 3
John Doe #1 #14 & Jane Doe #1 #2 v. Austin,
No. 3:21-cv-1211-AW-HTC, 2021 U.S. Dist. LEXIS 236327
(N.D. Fla. Nov. 12, 2021)........................................................................................ 9
O’Connor v. Donaldson,
422 U.S. 563 (1975) ................................................................................................ 4
Panhandle Eastern Pipeline Co. v. State Highway Commission,
294 U.S. 613 (1935) ................................................................................................ 5
Union Pac. Ry. Co. v. Botsford,
141 U.S. 250 (1891) ................................................................................................ 3
Vitek v. Jones,
445 U.S. 480 (1980) ................................................................................................ 4
Washington v. Harper,
494 U.S. 210 (1990) ................................................................................................ 3
STATUTES
21 U.S.C. § 360bbb-3...................................................................................................... 9
iii
TABLE OF AUTHORITIES—Continued
Page
OTHER AUTHORITIES
American College of Obstetricians and Gynecologists,
Ethical issues with vaccination in obstetrics and gynecology. Committee
Opinion No. 829. OBSTET GYNECOL 2021;138:e16-23. https://www.acog.org/
clinical/clinical-guidance/committee-opinion/articles/2021/07/ethical-issueswith-vaccination-in-obstetrics-and-gynecology ..................................................... 3
American Medical Association,
AMA Principles of Medical Ethics: I, II, V, VIII. Informed Consent. (2022)
https://www.ama-assn.org/delivering-care/ethics/informed-consent ................... 2
Brown CM, et al,
Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine
Breakthrough Infections, Associated with Large Public Gatherings —
Barnstable County, Massachusetts, July 2021. MMWR MORB MORTAL WKLY
REP 2021;70:1059-1062. https://www.cdc.gov/mmwr/volumes/70/wr/
mm7031e2.htm ..................................................................................................... 11
Bryant A, et al,
Ivermectin for prevention and treatment of COVID-19 infection: a systematic
review, meta-analysis, and trial sequential analysis to inform clinical
guidelines. AM J THER. 2021 Jun 21;28(4):e434-60. https://www.ncbi.nlm.nih.
gov/pmc/articles/PMC8248252/ .............................................................................. 7
C19early.com,
COVID-19 early treatment: real-time analysis of 2,118 studies [cited 2022
Sept 18]. https://c19early.com/ ............................................................................... 7
C19early.com,
COVID-19 studies: ivermectin; [cited 2022 Sept 18]. https://c19ivermectin.
com .......................................................................................................................... 7
C19early.com,
COVID-19 studies: vitamin D; [cited 2022 Sept 18]. https://c19vitamind.com ... 8
C19early.com,
HCQ for COVID-19: real-time meta analysis of 362 studies; [cited 2022 Sept
18]. https://hcqmeta.com ........................................................................................ 8
CDC (September 8, 2022),
Immunization Information Systems, COVID-19 Vaccine Related Codes. https:
//www.cdc.gov/vaccines/programs/iis/COVID-19-related-codes.html ................... 8
CDC,
Interim Public Health Recommendations for Fully Vaccinated People. Covid-
iv
TABLE OF AUTHORITIES—Continued
Page
19, Vaccines. Updated July 28, 2021. https://www.cdc.gov/coronavirus/2019-
ncov/vaccines/fully-vaccinated-guidance.html .................................................... 11
Centers for Disease Control and Prevention,
Washington, D.C.: U.S. Department of Health and Human Services. COVID
data tracker: trends in number of COVID-19 cases and deaths in the US
reported to CDC, by state/territory; [cited 2022 Apr 2]. https://covid.cdc.gov/
covid-data-tracker/#trends_totaldeaths .............................................................. 14
CNN Situation Room,
The Situation Room, interview with CDC Director Walensky. (August 5,
2021) https://twitter.com/CNNSitRoom/status/1423422301882748929 ............ 11
Colson, T.,
Top WHO scientist says vaccinated travelers should still quarantine, citing
lack of evidence that COVID-19 vaccines prevent transmission. BUSINESS
INSIDER. https://www.businessinsider.com/who-says-no-evidence-coronavirusvaccine-prevent-transmissions-2020-12?op=1 .................................................... 11
Dennis JM, et al,
Improving survival of critical care patients with coronavirus disease 2019 in
England: a national cohort study, March to June 2020. CRIT CARE MED. 2021
Feb 1;49(2):209-14. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803441/ .. 7
FDA Vaccines and Related Biological Products Advisory Committee,
FDA briefing document: Application for licensure of a booster dose for
Comirnaty (COVID-19 Vaccine, mRNA). FDA Vaccines and Related
Biological Products Advisory Committee Meeting: September 17, 2021. https:/
/www.fda.gov/media/152176/download .................................................................. 7
FDA Vaccines and Related Biological Products Advisory Committee,
FDA briefing document: EUA amendment request for a booster dose for the
Janssen COVID-19 vaccine. Vaccines and Related Biological Products
Advisory Committee Meeting: October 15, 2021. https://www.fda.gov/media/
153037/download. ................................................................................................... 6
Fraiman J, et al,
Serious adverse events of special interest following mRNA COVID-19
vaccination in randomized trials in adults. VACCINE. 2022 Sep
22;40(40):5798-5805. https://pubmed.ncbi.nlm.nih.gov/36055877/ ...................... 6
Horwitz LI, et al,
Trends in COVID-19 risk-adjusted mortality rates. J HOSP MED. 2021
Feb;16(2):90-2. https://www.journalofhospitalmedicine.com/jhospmed/article/
230561/hospital-medicine/trends-covid-19-risk-adjusted-mortality-rates. .......... 7
v
TABLE OF AUTHORITIES—Continued
Page
Ilie PC, et al,
The role of vitamin D in the prevention of coronavirus disease 2019 infection
and mortality. AGING CLIN EXP RES. 2020 Jul;32(7):1195-8. https://www.ncbi.
nlm.nih.gov/pmc/articles/PMC7202265/ ................................................................ 8
Ioannidis, JPA,
Reconciling estimates of global spread and infection fatality rates of COVID19: an overview of systematic evaluations. EUR J CLIN INVEST.
2021;51:e13554. https://onlinelibrary.wiley.com/doi/epdf/10.1111/eci.13554 ...... 7
Lin, DY, et al,
Letter to the Editor: Effects of Vaccination and Previous Infection on
Omicron Infections in Children. NEW ENGLAND JOURNAL OF MEDICINE.
(September 2022) https://www.nejm.org/doi/full/10.1056/NEJMc2209371 ......... 6
Manskar, N,
Moderna boss says COVID-19 vaccine not proven to stop spread of virus. NEW
YORK POST. (November 24, 2020) https://nypost.com/2020/11/24/modernaboss-says-covid-shot-not-proven-to-stop-virus-spread/ ....................................... 11
Mariner, W et al.,
Jacobson v. Massachusetts: It’s Not Your Great-Great-Grandfather’s Public
Health Law, 95 AM. J. PUB. HEALTH 581 (2005). https://www.ncbi.nlm.nih.
gov/pmc/articles/PMC1449224/ .............................................................................. 4
Massetti, PhD, et al.,
Summary of Guidance for Minimizing the Impact of COVID-19 on Individual
Persons, Communities, and Health Care Systems — United States, August
2022. Weekly/August 19, 2022/71(33);1057-1064. https://www.cdc.gov/mmwr/
volumes/71/wr/mm7133e1.htm ............................................................................ 12
Physicians for Informed Consent,
COVID-19 — Disease Information Statement (DIS). Aug 2021. https://
physiciansforinformedconsent.org/covid-19/ ......................................................... 7
Physicians for Informed Consent,
Janssen (Johnson & Johnson) COVID-19 Vaccine: Short-Term Efficacy &
Safety Data. May 2021. https://www.physiciansforinformedconsent.org/
COVID-19-vaccines ........................................................................................ 10, 13
Physicians for Informed Consent,
Moderna COVID-19 vaccine: short-term efficacy and safety data. Apr 2021.
https://www.physiciansforinformedconsent.org/COVID-19-vaccines................. 10
vi
TABLE OF AUTHORITIES—Continued
Page
Physicians for Informed Consent,
Pfizer-BioNTech COVID-19 vaccine: short-term efficacy and safety data. Jun
2021. https://www.physiciansforinformedconsent.org/COVID-19-vaccines ....... 10
Shitrit P, et al,
Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly
vaccinated population, Israel, July 2021. Euro Surveill. 2021 Sep;26(39).
https://pubmed.ncbi.nlm.nih.gov/34596015/ ....................................................... 12
Stieg, C,
Dr. Fauci on CDC mask guidelines: ‘We are dealing with a different virus now.
CNBC (July 28, 2021) https://www.cnbc.com/2021/07/28/dr-fauci-on-why-cdcchanged-guidelines-delta-is-a-different-virus.html ............................................... 11
Subramanian SV, et al,
Increases in COVID-19 are unrelated to levels of vaccination across 68
countries and 2947 counties in the United States. EUR J EPIDEMIOL. 2021 Sep
30:1-4. https://pubmed.ncbi.nlm.nih.gov/34591202/ ........................................... 12
Thomas SJ, et al,
C4591001 Clinical Trial Group. Safety and efficacy of the BNT162b2 mRNA
covid-19 vaccine through 6 months. N ENGL J MED. 2021 Nov 4;385(19):1761-
73. https://pubmed.ncbi.nlm.nih.gov/34525277 .................................................... 6
U.S. Food and Drug Administration,
Vaccines and Related Biological Products Advisory Committee. FDA briefing
document: Janssen Ad26.COV2.S vaccine for the prevention of COVID-19.
Vaccines and Related Biological Products Advisory Committee Meeting:
February 26, 2021. https://www.fda.gov/media/146217/download ............... 10, 13
U.S. Food and Drug Administration,
Vaccines and Related Biological Products Advisory Committee. FDA briefing
document: Moderna COVID-19 vaccine. Vaccines and Related Biological
Products Advisory Committee Meeting: December 17, 2020. https://www.fda.
gov/media/144434/download ................................................................................ 10
U.S. Food and Drug Administration,
Vaccines and Related Biological Products Advisory Committee. FDA briefing
document: Pfizer-BioNTech COVID-19 vaccine. Vaccines and Related
Biological Products Advisory Committee Meeting: December 10, 2020. https:/
/www.fda.gov/media/144245/download ............................................................... 10
1
IDENTITY AND INTEREST OF AMICUS CURIAE1
Amicus Curiae is PHYSICIANS FOR INFORMED CONSENT (“PIC”), a 501(c)(3)
educational nonprofit organization focused on science and statistics. PIC delivers
data on infectious diseases and vaccines, and unites doctors, scientists, healthcare
professionals, attorneys, and families who support voluntary vaccination. In
addition, its COALITION FOR INFORMED CONSENT consists of about 300 U.S. and
international organizations.
This brief is submitted pursuant to leave requested by the unopposed
accompanying motion.
SUMMARY OF ARGUMENT
Respondents’ vaccine mandate would not pass strict scrutiny for scientific
reasons, because there is no legal or scientific justification for Respondents to
discriminate against unvaccinated people.
There is no evidence that any of the currently available COVID-19 vaccines
prevent the infection or transmission of SARS-CoV-2 or COVID-19, and in fact there
is evidence that the spread of SARS-CoV-2 occurs in spite of vaccination. CDC data
show mass vaccination with the COVID-19 vaccine has had no measurable impact
on the COVID-19 mortality rate in the U.S.
1 Amicis curiae states that no counsel for a party authored any part of this brief, and no person or
entity other than amicus and their counsel made a monetary contribution to the preparation or
submission of this brief.
2
Yet there is evidence that the vaccines have a rapidly declining effect on
immunity within just a few months, to the point of zero immunity within six
months. Previous SARS-CoV-2 or COVID-19 infection is more effective at
preventing SARS-CoV-2 or COVID-19 infection than COVID-19 vaccines, thereby
removing any purported justification for depriving unvaccinated people of their
Constitutionally protected rights. Those previously infected with COVID-19 should
not have less rights than those vaccinated for COVID-19.
ARGUMENT
A. INFORMED
CONSENT/REFUSAL
IN
VACCINATION
IS
A
FUNDAMENTAL
RIGHT
TRIGGERING STRICT SCRUTINY.
Universally recognized by physicians, informed consent/refusal in vaccination is
a fundamental right, as it is essential to the patient’s bodily integrity. See e.g.,
Informed consent to medical treatment is fundamental in both ethics and
law. Patients have the right to receive information and ask questions
about recommended treatments so that they can make well-considered
decisions about care. Successful communication in the patient-physician
relationship fosters trust and supports shared decision making.” Citation:
American Medical Association (2022), AMA Principles of Medical Ethics: I,
II, V, VIII. Informed Consent. https://www.ama-assn.org/delivering-care/
ethics/informed-consent.
Informed consent is a core component of the ethical clinical relationship.
As with all forms of medical therapy, informed consent should precede
vaccination administration . . . If the patient declines, this informed
refusal of recommended vaccination should be respected . . . .Patients who
decline vaccination should continue to be supported with appropriate care
options that honor their autonomous choices.”
Ethical issues with vaccination in obstetrics and gynecology. (2021) Committee
Opinion No. 829. American College of Obstetricians and Gynecologists.
3
OBSTET GYNECOL 2021;138:e16-23. https://www.acog.org/clinical/clinical-guidance/
committee-opinion/articles/2021/07/ethical-issues-with-vaccination-in-obstetricsand-gynecology.
Safeguarding informed consent/refusal is indeed essential to a successful doctorpatient relationship. Vaccination carries risk of harm and is an invasive medical
procedure. For a state or federally funded institution to engage in coercing this
medical procedure upon patients (by threating to strip their livelihood) is a direct
infringement upon the right of bodily integrity.
The fundamental right of bodily integrity has been well recognized in the
United States. As this Supreme Court found in Union Pac. Ry. Co. v. Botsford, 141
U.S. 250, 251 (1891), “No right is held more sacred, or is more carefully guarded by
the common law, than the right of every individual to the possession and control of
his own person, free from all restraint or interference of others, unless by clear and
unquestionable authority of law.” See also Washington v. Harper, 494 U.S. 210, 229
(1990) (“The forcible injection of medication into a nonconsenting person’s body
represents a substantial interference with that person’s liberty.”)
Petitioner’s brief discusses a method advocated by legal scholars to bring
Jacobson v. Massachusetts, 197 U.S. 11 (1905) in line with intermediate scrutiny if
not strict scrutiny.
For example, applying Jacobson to the modern day, leading scholars at Boston
University published wisely:
Public health programs that are based on force are a relic of the 19th
century; 21st century public health depends on good science, good
communication, and trust in public health officials to tell the truth. In each
of these spheres, constitutional rights are the ally rather than the enemy
4
of public health. Preserving the public’s health in the 21st century requires
preserving respect for personal liberty.
Even in an emergency, when there is a rapidly spreading contagious
disease and an effective vaccine, the state is not permitted to forcibly
vaccinate or medicate anyone. The constitutional alternative is to
segregate infected and exposed people separately [allowing selfquarantine] to prevent them from transmitting the disease to others.
While [the Supreme Court] has not decided a case that involved isolation
or quarantine for disease, it has held that civil commitment for mental
illness is unconstitutional unless a judge determines the person is
dangerous by reason of a mental illness [citations omitted]. Assuming, as
most scholars do, that the law governing commitment to a mental
institution also applies to involuntary confinement for contagious diseases,
the government would have the burden of proving, by “clear and
convincing evidence,” that the individual actually has, or has been exposed
to, a contagious disease and is likely to transmit the disease to others if not
confined [citations omitted].
In cases that involve civil commitment or involuntary hospitalization for
mental illness, the Court has required the state to prove—by clear and
convincing evidence—that a person is mentally ill and that the illness
renders the person dangerous to others. Foucha v. Louisiana, 504 U.S. 71
(1992), Carey v. Population Services Intl, 431 U.S. 678 (1977), O’Connor v.
Donaldson, 422 U.S. 563, 580 (1975), Addington v. Texas, 441 U.S. 418,
425 (1979), Vitek v. Jones, 445 U.S. 480, 494 (1980).
When the HIV epidemic began in 1981, these principles from the 1970s
reminded legislators at both the state and federal levels that people could
not be involuntarily detained simply because they had HIV infection. Only
a few individuals who imminently threatened to infect other people by
deliberate or uncontrollable behavior would meet the constitutional test.
More recently, the same approach has been used by lower courts in some
cases that involved people who had active, contagious tuberculosis. City of
Newark v. JS, 279 N.J. Super. 178 (1993). Green v. Edwards, 164 W.Va.
326 (1980).
Jacobson v. Massachusetts: It’s Not Your Great-Great-Grandfather’s Public Health
Law, 95 AM. J. PUB. HEALTH 581, 588 (2005). https://www.ncbi.nlm.nih.gov/pmc/
articles/PMC1449224/.
5
Petitioner Marciano’s brief (at page 32) references the quarantine rights and
procedures meant to govern New York City. If such procedures had been actually
implemented faithfully as individualized due process, there would have been little
room for executive rule by fiat. The vaccine mandates that have transpired in New
York City since 2021, and indeed throughout the Nation, have circumvented
individualized due process, to the extent due process should require the government
to meet a meaningful burden of proof before tribunals making evidentiary findings
at individualized hearings. Such due process would have provided, as the New York
legislature appears to have intended, checks and balances against executive rule by
fiat.
In Panhandle Eastern Pipeline Co. v. State Highway Commission, 294 U.S. 613,
622 (1935), this Court stated famously,
The police power of a state, while not susceptible of definition with
circumstantial precision, must be exercised within a limited ambit and is
subordinate to constitutional limitations. It springs from the obligation of
the state to protect its citizens and provide for the safety and good order of
society. Under it there is no unrestricted authority to accomplish whatever
the public may presently desire. It is the governmental power of selfprotection and permits reasonable regulation of rights and property in
particulars essential to the preservation of the community from injury.
Public health authority is not unlimited, but rather is limited by courts
assessing whether injury is being done to individuals and the community. The
scientific authorities presented in this amicus brief are intended to so aid the Court,
especially to the extent the burden should be upon the government to meet strict
scrutiny.
6
Here are some of the key data points highlighting the importance of informed
consent, which further emphasize that Respondents’ vaccine mandate should not
survive any level of scrutiny:
Because all subjects in the COVID-19 clinical trials were observed for only two
to six months, the long-term safety of COVID-19 vaccines for any age group is not
known. Meanwhile, substantial risks of the vaccine are increasingly calculable, such
as myocarditis and pericarditis.2
The clinical trials detected that vaccine immunity wanes significantly over a
short period of time. For example, the Pfizer vaccine efficacy decreased by 8% to
18% within only six months, and the Johnson & Johnson vaccine efficacy decreased
by 25% to 29% within only six months.3 Additionally, the efficacy measured in the
clinical trials was against the original Wuhan strain, not the new variants.
In clinical trials, a third dose of Pfizer or Moderna vaccine or a second dose of
Johnson & Johnson vaccine has not been evaluated for efficacy against disease, but
2 Fraiman J, et al (September 2022). Serious adverse events of special interest following mRNA
COVID-19 vaccination in randomized trials in adults. VACCINE. 2022 Sep 22;40(40):5798-5805. https:
//pubmed.ncbi.nlm.nih.gov/36055877/
3 Thomas SJ, et al (November 2021), C4591001 Clinical Trial Group. Safety and efficacy of the
BNT162b2 mRNA covid-19 vaccine through 6 months. N ENGL J MED. 2021 Nov 4;385(19):1761-73.
https://pubmed.ncbi.nlm.nih.gov/34525277.
FDA (October 2021). Vaccines and Related Biological Products Advisory Committee. FDA briefing
document: EUA amendment request for a booster dose for the Janssen COVID-19 vaccine. Vaccines
and Related Biological Products Advisory Committee Meeting: October 15, 2021. https://www.fda.
gov/media/153037/download.
See also, Lin, DY, et al (September 2022), Letter to the Editor: Effects of Vaccination and Previous
Infection on Omicron Infections in Children. NEW ENGLAND JOURNAL OF MEDICINE. https://www.
nejm.org/doi/full/10.1056/NEJMc2209371 (“rapid decline in protection”)
7
rather antibody counts were observed in a small number of vaccinated subjects for
only one month.4
Treatments for COVID-19 have improved significantly since the pandemic
began in early 2020, resulting in improved survival rates in hospitalized cases.5
Indeed, for people not living in a nursing home, the overall survival rate of COVID19 is 99.8% in the U.S., and 99.999% for children specifically.6
Hundreds of studies have observed the effectiveness of various treatments,
the most studied being ivermectin, vitamin D, hydroxychloroquine (HCQ), and
monoclonal antibodies.7 These treatments may also be beneficial for prophylaxis
(i.e., pre-exposure or post-exposure prevention of symptomatic COVID-19
infections).8
4 See footnote 2, and FDA (September 2021). Vaccines and Related Biological Products Advisory
Committee. FDA briefing document: Application for licensure of a booster dose for Comirnaty
(COVID-19 Vaccine, mRNA). Vaccines and Related Biological Products Advisory Committee
Meeting: September 17, 2021. https://www.fda.gov/media/152176/download.
5 Horwitz LI, et al (2021) Trends in COVID-19 risk-adjusted mortality rates. J HOSP MED. 2021
Feb;16(2):90-2.
https://www.journalofhospitalmedicine.com/jhospmed/article/230561/hospital-medicine/
trends-covid-19-risk-adjusted-mortality-rates.
Dennis JM, et al (2021). Improving survival of critical care patients with coronavirus disease 2019 in
England: a national cohort study, March to June 2020. CRIT CARE MED. 2021 Feb 1;49(2):209-14.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803441/.
6 Ioannidis, JPA. Reconciling estimates of global spread and infection fatality rates of COVID- 19: an
overview of systematic evaluations. EUR J CLIN INVEST. 2021;51:e13554. https://onlinelibrary.wiley.
com/doi/epdf/10.1111/eci.13554.
Physicians for Informed Consent (2021). COVID-19 — Disease Information Statement (DIS). Aug
2021. https://physiciansforinformedconsent.org/covid-19/.
7 C19early.com. COVID-19 early treatment: real-time analysis of 2,118 studies [cited 2022 Sept 18].
https://c19early.com/.
8 C19early.com. COVID-19 studies: ivermectin; [cited 2022 Sept 18]. https://c19ivermectin.com.
Bryant A, et al (2021). Ivermectin for prevention and treatment of COVID-19 infection: a systematic
review, meta-analysis, and trial sequential analysis to inform clinical guidelines. AM J THER. 2021
Jun 21;28(4):e434-60. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248252/.
8
Ultimately, history favors those who uphold civil rights, such as Petitioner.
As a housecleaning matter, Petitioner Marciano’s brief states at pages 25 and
31,
A majority of this Court would likely agree, as it did in NFIB, the City
Respondents’ have no inherent legislative authority to engage in
fundamental, medical policy decisions reserved for the legislature . . . A
majority of this Court would likely agree this case is not about police power
to mandate a legislatively authorized vaccination as erroneously
determined below.
Amicus Curiae concurs this case does not concern a legislative vaccine mandate.
However, had the New York legislature explicitly granted authority to the mayor to
mandate a COVID-19 vaccine on city employees, amicus submits a mandate would
still violate strict scrutiny for the scientific and ethical reasons stated herein, which
are in addition to the reasons stated in Petitioner’s brief.
Amicus was unable to locate any evidence in this case that an FDA-approved
COVID-19 vaccine (Comirnaty or Spikevax) was available to Petitioner Anthony
Marciano. This absence of evidence appears consistent with healthcare observations
in real-time that EUA label vaccines are widely available, but not FDA-approved
vaccines. See CDC (September 8, 2022). Immunization Information Systems,
COVID-19 Vaccine Related Codes. https://www.cdc.gov/vaccines/programs/iis/COVID19-related-codes.html (“These vaccines are listed separately because they represent
C19early.com. COVID-19 studies: vitamin D; [cited 2022 Sept 18]. https://c19vitamind.com.
Ilie PC, et al (2020). The role of vitamin D in the prevention of coronavirus disease 2019 infection
and mortality. AGING CLIN EXP RES. 2020 Jul;32(7):1195-8. https://www.ncbi.nlm.nih.gov/pmc/
articles/PMC7202265/.
C19early.com. HCQ for COVID-19: real-time meta analysis of 362 studies; [cited 2022 Sept 18].
https://hcqmeta.com.
9
NDCs that will not be manufactured or made available in the near term even if
authorized.”)
This supports Petitioner’s statutory argument for informed consent pursuant to
21 U.S.C. § 360bbb-3; John Doe #1 #14 & Jane Doe #1 #2 v. Austin, No. 3:21-cv1211-AW-HTC, 2021 U.S. Dist. LEXIS 236327, at *17 (N.D. Fla. Nov. 12, 2021)
(finding that EUA vaccines cannot be mandated, “Because the plaintiffs have not
shown they are (or will be) required to receive an EUA-labeled, non-BLA-compliant
vaccine, the plaintiffs have not shown a likelihood of success”).
B. THERE IS NO EVIDENCE THAT COVID-19 VACCINES PREVENT THE INFECTION OR
TRANSMISSION OF SARS-COV-2 OR COVID-19, AND IN FACT THERE IS EVIDENCE TO
THE CONTRARY (THAT IT HAS A NEGATIVE EFFECT ON IMMUNITY)
Government statements confirm there is no evidence that COVID-19 vaccines
prevent the spread of SARS-CoV-2 or COVID-19.
Therefore,
there
is
no
scientific
justification
to
discriminate
against
unvaccinated people. Clinical trials for the Pfizer-BioNTech, Moderna, and Janssen
(Johnson & Johnson) COVID-19 vaccines were not designed to observe
asymptomatic infection with SARS-CoV-2 or the effect of the vaccine on the spread
(transmission) of COVID-19. Consequently, in its briefing document for each
vaccine, the U.S. Food and Drug Administration (FDA) states that “it is possible
that asymptomatic infections may not be prevented as effectively as symptomatic
infections” and “data are limited to assess the effect of the vaccine against
transmission of SARS-CoV-2 from individuals who are infected despite vaccination.”
Furthermore, “additional evaluations including data from clinical trials and from
10
vaccine use post-authorization will be needed to assess the effect of the vaccine in
preventing virus shedding and transmission, in particular in individuals with
asymptomatic infection.” Citations:
1. U.S. Food and Drug Administration, Vaccines and Related Biological
Products Advisory Committee. FDA briefing document: Pfizer-BioNTech
COVID-19 vaccine. Vaccines and Related Biological Products Advisory
Committee Meeting: December 10, 2020. https://www.fda.gov/media/
144245/download.
2. Physicians for Informed Consent. Pfizer-BioNTech COVID-19 vaccine:
short-term efficacy and safety data. Jun 2021. https://www.physicians
forinformedconsent.org/COVID-19-vaccines.
3. U.S. Food and Drug Administration, Vaccines and Related Biological
Products Advisory Committee. FDA briefing document: Moderna COVID-19
vaccine. Vaccines and Related Biological Products Advisory Committee
Meeting: December 17, 2020. https://www.fda.gov/media/144434/download.
4. Physicians for Informed Consent. Moderna COVID-19 vaccine: short-term
efficacy and safety data. Apr 2021. https://www.physiciansforinformed
consent.org/COVID-19-vaccines.
5. U.S. Food and Drug Administration, Vaccines and Related Biological
Products Advisory Committee. FDA briefing document: Janssen
Ad26.COV2.S vaccine for the prevention of COVID-19. Vaccines and Related
Biological Products Advisory Committee Meeting: February 26, 2021. https:/
/www.fda.gov/media/146217/download.
6. Physicians for Informed Consent. Janssen (Johnson & Johnson) COVID-19
Vaccine: Short-Term Efficacy & Safety Data. May 2021. https://www.
physiciansforinformedconsent.org/COVID-19-vaccines.
For over one year now, government statements have repeatedly confirmed that
COVID-19 vaccines do not prevent the spread of SARS-CoV-2 or COVID-19, and
that both vaccinated and unvaccinated persons equally transmit the virus. For
example:
11
●
NIAID Director Dr. Anthony Fauci: “We know now as a fact that [vaccinated
people with Covid-19] are capable of transmitting the infection to someone
else.”9
●
CDC Director Dr. Rochelle Walensky: “[W]hat the [vaccines] can’t do
anymore is prevent transmission.”10
●
WHO Chief Scientist Dr. Soumya Swaminathan: “At the moment I don’t
believe we have the evidence of any of the vaccines to be confident that it’s
going to prevent people from actually getting the infection and therefore
being able to pass it on.”11
●
Chief Medical Officer of Moderna Dr. Tal Zaks: “There’s no hard evidence
that [the vaccine] stops them from carrying the virus transiently and
potentially infecting others who haven’t been vaccinated.”12
And these admissions from government officials have been supported by realtime data, such as the CDC study of one COVID-19 outbreak in July 2021 where
74% of cases were fully vaccinated. 13
9 Stieg, C (July 28, 2021), Dr. Fauci on CDC mask guidelines: ‘We are dealing with a different virus
now. https://www.cnbc.com/2021/07/28/dr-fauci-on-why-cdc-changed-guidelines-delta-is-a-different-virus.
html.
10 CNN (August 5, 2021), The Situation Room, interview with CDC Director Walensky. https://
twitter.com/CNNSitRoom/status/1423422301882748929.
11 Colson, T. (December 29, 2020), Top WHO scientist says vaccinated travelers should still
quarantine, citing lack of evidence that COVID-19 vaccines prevent transmission. BUSINESS INSIDER.
https://www.businessinsider.com/who-says-no-evidence-coronavirus-vaccine-prevent-transmissions2020-12?op=1.
12 Manskar, N (November 24, 2020). Moderna boss says COVID-19 vaccine not proven to stop
spread of virus. NEW YORK POST. https://nypost.com/2020/11/24/moderna-boss-says-covid-shot-notproven-to-stop-virus-spread/.
13 Brown CM, et al (2021). Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine
Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County,
Massachusetts, July 2021. MMWR MORB MORTAL WKLY REP 2021;70:1059-1062. https://www.cdc.
gov/mmwr/volumes/70/wr/mm7031e2.htm.
Another CDC statement highlighting this, “ . . .preliminary evidence suggests that fully vaccinated
people who do become infected with the Delta variant can spread the virus to others.” CDC. Interim
Public Health Recommendations for Fully Vaccinated People. Covid-19, Vaccines. Updated July 28,
2021. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated-guidance.html.
12
Another study of a COVID-19 outbreak in July 2021 published in
Eurosurveillance found that “all transmissions between patients and staff occurred
between masked and vaccinated individuals, as experienced in an outbreak from
Finland.” The authors state that the study “challenges the assumption that high
universal vaccination rates will lead to herd immunity and prevent COVID-19
outbreaks.”14
A Harvard study investigating COVID-19 cases across 68 countries and across
2,947 counties in the U.S. found “no significant signaling of COVID-19 cases
decreasing with higher percentages of population fully vaccinated.”15
C. THOSE PREVIOUSLY INFECTED WITH COVID-19 SHOULD NOT HAVE LESS RIGHTS
THAN THOSE VACCINATED FOR COVID-19
There is evidence that previous SARS-CoV-2 or COVID-19 infection is more
effective at preventing SARS-CoV-2 or COVID-19 infection than COVID-19
vaccines. Therefore, it follows that those previously infected with COVID-19 should
not have less rights than those vaccinated for COVID-19.
Recent CDC guidance recognizes vaccinated and unvaccinated people should be
treated alike for COVID-19 testing purposes.16
14 Shitrit P, et al (2021). Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly
vaccinated population, Israel, July 2021. Euro Surveill. 2021 Sep;26(39). https://pubmed.ncbi.nlm.
nih.gov/34596015/.
15 Subramanian SV, et al (2021). Increases in COVID-19 are unrelated to levels of vaccination
across 68 countries and 2947 counties in the United States. EUR J EPIDEMIOL. 2021 Sep 30:1-4. https:
//pubmed.ncbi.nlm.nih.gov/34591202/.
16 Massetti, PhD, et al. (August 2022), Summary of Guidance for Minimizing the Impact of COVID19 on Individual Persons, Communities, and Health Care Systems — United States, August 2022.
Weekly/August 19, 2022/71(33);1057-1064. https://www.cdc.gov/mmwr/volumes/71/wr/mm7133e1.
htm (“When implemented, screening testing strategies should include all persons, irrespective of
vaccination status.”)
13
The Janssen (Johnson & Johnson) COVID-19 vaccine clinical trial included over
2,000 subjects that had contracted SARS-CoV-2 before the study. The trial recorded
the incidence of COVID-19 in that unvaccinated group at least 28 days after the
vaccination of the other subjects in the study. The COVID-19 incidence of the
unvaccinated group with prior SARS-CoV-2 infection was 0.1% (2/2,021), whereas
the COVID-19 incidence of vaccinated subjects was 0.59% (113/19,306). These data
suggest that there are six times more cases of COVID-19 in vaccinated subjects
than in unvaccinated subjects previously infected with SARS-CoV-2. This also
means that an unvaccinated person previously infected with SARS-CoV-2 has 99.9%
chance of being protected from a repeat infection. 17
D. COVID-19 VACCINES HAVE HAD NO MEASURABLE IMPACT ON THE COVID-19
MORTALITY RATE
CDC data show mass vaccination with COVID-19 vaccines has had no
measurable impact on the COVID-19 mortality rate in the U.S. In the nine months
before the introduction of mass vaccination (April 2020 through December 2020),
there were about 356,000 COVID-19 deaths or 39,500 deaths per month — a
mortality rate of 0.120 per 1,000 people. In the nine months after the introduction of
mass vaccination (January 2021 through September 2021), there were 342,000
17 Physicians for Informed Consent. Janssen (Johnson & Johnson) COVID-19 Vaccine: Short-Term
Efficacy & Safety Data. May 2021. https://www.physiciansforinformedconsent.org/COVID-19vaccines.
FDA (2021). Vaccines and Related Biological Products Advisory Committee. FDA briefing document:
Janssen Ad26.COV2.S vaccine for the prevention of COVID-19. Vaccines and Related Biological
Products Advisory Committee Meeting: February 26, 2021. Table 14: vaccine efficacy of first
occurrence of moderate to severe/critical COVID-19, including non-centrally confirmed cases, with
onset at least 14 or at least 28 days after vaccination, by baseline SARS-CoV-2 status, per protocol
set; 30. https://www.fda.gov/media/146217/download.
14
COVID-19 deaths or 38,000 deaths per month — a mortality rate of 0.115 per 1,000
people. And in the five months that followed (October 2021 through February 2022),
there were an additional 249,000 COVID-19 deaths or 49,800 deaths per month — a
mortality rate of 0.151 per 1,000 people.18
18 Centers for Disease Control and Prevention. Washington, D.C.: U.S. Department of Health and
Human Services. COVID data tracker: trends in number of COVID-19 cases and deaths in the US
reported to CDC, by state/territory; [cited 2022 Apr 2]. https://covid.cdc.gov/covid-data-tracker/
#trends_totaldeaths.
15
CONCLUSION
Petitioner should retain the right and dignity of informed consent/refusal
without penalty. The scientific data demonstrate that vaccine mandates have not
been proven to create a safer environment. Applying strict scrutiny, Respondents’
vaccine mandate fails to advance a compelling government interest that is narrowly
tailored to protect public health. If there is any doubt here, it helps to remember
that history favors upholding civil rights.
Respectfully submitted,
/s/ Gregory J. Glaser
GREGORY J. GLASER
COUNSEL OF RECORD
4399 BUCKBOARD DRIVE #423
COPPEROPOLIS, CA 95228
(925) 642-6651
GREG@PICPHYSICIANS.ORG
COUNSEL FOR AMICUS CURIAE
PHYSICIANS FOR INFORMED CONSENT
SEPTEMBER 24, 2022
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.